Related Experiment Video
Updated: Apr 21, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis
Andreas Essig1, Daniela Hofmann2, Daniela Münch3
1From the Institute of Microbiology and.
Abstract:
Fungi and bacteria compete with an arsenal of secreted molecules for their ecological niche. This repertoire represents a rich and inexhaustible source for antibiotics and fungicides. Antimicrobial peptides are an emerging class of fungal defense molecules that are promising candidates for pharmaceutical applications. Based on a co-cultivation system, we studied the interaction of the coprophilous basidiomycete Coprinopsis cinerea with different bacterial species and identified a novel defensin, copsin. The polypeptide was recombinantly produced in Pichia pastoris, and the three-dimensional structure was solved by NMR. The cysteine stabilized α/β-fold with a unique disulfide connectivity, and an N-terminal pyroglutamate rendered copsin extremely stable against high temperatures and protease digestion. Copsin was bactericidal against a diversity of Gram-positive bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes. Characterization of the antibacterial activity revealed that copsin bound specifically to the peptidoglycan precursor lipid II and therefore interfered with the cell wall biosynthesis. In particular, and unlike lantibiotics and other defensins, the third position of the lipid II pentapeptide is essential for effective copsin binding. The unique structural properties of copsin make it a possible scaffold for new antibiotics.
Insights
Researchers discovered copsin, a novel antimicrobial peptide from the fungus Coprinopsis cinerea. This highly stable peptide targets bacterial cell wall synthesis, showing potential as a new antibiotic scaffold.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Fungi and bacteria produce secreted molecules for ecological competition, serving as sources for antimicrobials.
- Antimicrobial peptides (AMPs) are emerging fungal defense molecules with pharmaceutical potential.
Purpose of the Study:
- To investigate the interaction between the basidiomycete Coprinopsis cinerea and bacteria.
- To identify and characterize novel antimicrobial compounds produced by C. cinerea.
Main Methods:
- Co-cultivation of C. cinerea with bacteria.
- Recombinant production of the identified peptide (copsin) in Pichia pastoris.
- NMR spectroscopy for three-dimensional structure determination.
- Antibacterial assays against Gram-positive bacteria.
- Mechanism of action studies, including binding to lipid II.
Main Results:
- Identification of a novel defensin, copsin, from C. cinerea.
- Copsin exhibits high stability due to its cysteine-stabilized α/β-fold, unique disulfide connectivity, and N-terminal pyroglutamate.
- Copsin demonstrates bactericidal activity against Gram-positive bacteria, including pathogens like Enterococcus faecium and Listeria monocytogenes.
- Copsin binds to lipid II, inhibiting bacterial cell wall biosynthesis.
- Effective binding requires interaction at the third position of the lipid II pentapeptide, distinct from other defensins and lantibiotics.
Conclusions:
- Copsin is a novel, highly stable antimicrobial peptide with a unique mechanism of action.
- Its specific interaction with lipid II suggests potential for developing new antibiotics targeting cell wall biosynthesis.
- The structural features of copsin provide a promising scaffold for novel antimicrobial drug development.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Antifungal Agents
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Peptidoglycan Synthesis
Production of Antibiotics

